Tyrosine kinase inhibitor and rituximab‐CHOP treatment for concurrent chronic myeloid leukemia and non‐Hodgkin lymphoma: a case report

Non‐Hodgkin lymphoma can occur concurrently with chronic phase‐chronic myeloid leukemia (CML) at initial diagnosis. Combination treatment with second‐generation tyrosine kinase inhibitors and rituximab‐CHOP for patients newly diagnosed with CML and non‐Hodgkin lymphoma is effective for both diseases...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Case Rep
Main Authors: Takeyasu, Yuki, Satake, Atsushi, Azuma, Yoshiko, Tsubokura, Yukie, Yoshimura, Hideaki, Hotta, Masaaki, Nakanishi, Takahisa, Fujita, Shinya, Nakaya, Aya, Ito, Tomoki, Nomura, Shosaku
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2017
Assuntos:
Case Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5715580/
https://ncbi.nlm.nih.gov/pubmed/29225854
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.1253
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados